相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year
Stephanie Belaiche et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2018)
Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation
Benaya Rozen-Zvi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Is trough level variability the new tool for identifying patients at risk for rejection after transplantation?
Uwe Heemann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation
John A. O'Regan et al.
JOURNAL OF NEPHROLOGY (2016)
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients
T. Vanhove et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Thomas Vanhove et al.
DRUG METABOLISM REVIEWS (2016)
A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation
Nauras Shuker et al.
TRANSPLANT INTERNATIONAL (2016)
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development
Emilio Rodrigo et al.
TRANSPLANTATION (2016)
Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients
C. -T. Huang et al.
TRANSPLANTATION PROCEEDINGS (2016)
Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
Ruth Sapir-Pichhadze et al.
KIDNEY INTERNATIONAL (2014)
Medication Level Variability Index Predicts Rejection, Possibly Due to Nonadherence, in Adult Liver Transplant Recipients
Christina Supelana et al.
LIVER TRANSPLANTATION (2014)
Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring
Dirk R. J. Kuypers et al.
TRANSPLANTATION (2013)
Epigenomics and Interindividual Differences in Drug Response
M. Ivanov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Food-drug Interaction of Tacrolimus with Pomelo, Ginger, and Turmeric Juice in Rats
Kanoko Egashira et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients
Ming-Ju Wu et al.
TRANSPLANTATION (2011)
Explaining variability in ciclosporin exposure in adult kidney transplant recipients
Rogier R. Press et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
Lennaert C. P. Borra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Kai-Uwe Eckardt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Cytochrome p450 3A4 and p-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea
W Lemahieu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients
K Sato et al.
CLINICAL TRANSPLANTATION (2004)
Mechanisms of clinically relevant drug interactions associated with tacrolimus
U Christians et al.
CLINICAL PHARMACOKINETICS (2002)
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects
I Bekersky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
